<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="117833">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02125669</url>
  </required_header>
  <id_info>
    <org_study_id>FF57/2012</org_study_id>
    <nct_id>NCT02125669</nct_id>
  </id_info>
  <brief_title>Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas</brief_title>
  <official_title>The Role of the 595 nm Pulsed Dye Laser in Treating Superficial Basal Cell Carcinomas at Low Risk Anatomical Sites: Outcome of a Double Blind Randomized Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hautklinik Darmstadt</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hautklinik Darmstadt</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pulsed dye laser (PDL) treatments have been suggested to be a safe and effective therapeutic
      approach for treating basal cell carcinomas. Robust supporting evidence is, however, lacking
      due to inconsistent design of available studies. The purpose of this study is to evaluate
      the PDL's efficacy and safety in treating superficial basal cell carcinoma (sBCC) at low
      risk anatomical sites in an evidence based study setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>complete response</measure>
    <time_frame>9 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>patients satisfaction</measure>
    <time_frame>9 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>side effects</measure>
    <time_frame>9 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>reduction of tumor diameter and tumor thickness</measure>
    <time_frame>9 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Laser Treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulsed dye laser 595nm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SHAM Treatment</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>using the pulsed dye laser (PDL) laser without releasing a pulse</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laser treatment</intervention_name>
    <description>Pulsed dye laser 595nm</description>
    <arm_group_label>Laser Treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SHAM-Treatment</intervention_name>
    <description>using the pulsed dye laser (PDL) laser without releasing a pulse</description>
    <arm_group_label>SHAM Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histologically confirmed unpigmented sBCC on the trunk and extremities

          -  maximal tumour diameter 30 mm

        Exclusion Criteria:

          -  Fitzpatrick skin type &gt;III

          -  pregnancy

          -  previous BCC treatment within 4 weeks

          -  coagulation disorders

          -  photo sensitizing medication

          -  any indication of poor compliance
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maurizio Podda, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hautklinik Darmstadt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Syrus Karsai, Dr.</last_name>
    <role>Study Director</role>
    <affiliation>Hautklinik Darmstadt</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heiko Friedl</last_name>
    <role>Study Chair</role>
    <affiliation>Hautklinik Darmstadt</affiliation>
  </overall_official>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 27, 2014</lastchanged_date>
  <firstreceived_date>April 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hautklinik Darmstadt</investigator_affiliation>
    <investigator_full_name>Maurizio Podda</investigator_full_name>
    <investigator_title>PD Dr. med.</investigator_title>
  </responsible_party>
  <keyword>basal cell carcinoma</keyword>
  <keyword>laser surgery</keyword>
  <keyword>pulsed dye laser</keyword>
  <keyword>randomized controlled trial</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
